The Breathlessness, Cough, and Sputum Scale

Nancy Kline Leidy(Health Outcomes Solutions (United States)), Mitch Goldman(AstraZeneca (United States)), Jordana K. Schmier, Stephen I. Rennard(University of Nebraska at Omaha), M. Kathryn C. Jones(AstraZeneca (United States))
CHEST Journal
December 1, 2003
10.1378/chest.124.6.2182
Cited by 126

Related Papers

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
|European Respiratory Journal|2004|4.4k
Development and first validation of the COPD Assessment Test
|European Respiratory Journal|2009|3.2k
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
|New England Journal of Medicine|2010|3k
Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 2—Assessing Respondent Understanding
|Value in Health|2011|1.1k
Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 1—Eliciting Concepts for a New PRO Instrument
|Value in Health|2011|1.1k